These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21293484)

  • 1. Surface properties: Immune attack on nanoparticles.
    Sim RB; Wallis R
    Nat Nanotechnol; 2011 Feb; 6(2):80-1. PubMed ID: 21293484
    [No Abstract]   [Full Text] [Related]  

  • 2. Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption.
    Al-Hanbali O; Rutt KJ; Sarker DK; Hunter AC; Moghimi SM
    J Nanosci Nanotechnol; 2006; 6(9-10):3126-33. PubMed ID: 17048527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein ultrastructure and the nanoscience of complement activation.
    Vorup-Jensen T; Boesen T
    Adv Drug Deliv Rev; 2011 Sep; 63(12):1008-19. PubMed ID: 21699938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators.
    Vittaz M; Bazile D; Spenlehauer G; Verrecchia T; Veillard M; Puisieux F; Labarre D
    Biomaterials; 1996 Aug; 17(16):1575-81. PubMed ID: 8842361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CH(50): a revisited hemolytic complement consumption assay for evaluation of nanoparticles and blood plasma protein interaction.
    Meerasa A; Huang JG; Gu FX
    Curr Drug Deliv; 2011 May; 8(3):290-8. PubMed ID: 21291380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties.
    Zambaux MF; Bonneaux F; Gref R; Dellacherie E; Vigneron C
    J Biomed Mater Res; 1999 Jan; 44(1):109-15. PubMed ID: 10397910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of PEG chain on the complement activation suppression and longevity in vivo prolongation of the PCL biomedical nanoparticles.
    Shan X; Yuan Y; Liu C; Tao X; Sheng Y; Xu F
    Biomed Microdevices; 2009 Dec; 11(6):1187-94. PubMed ID: 19609680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering.
    Hamad I; Al-Hanbali O; Hunter AC; Rutt KJ; Andresen TL; Moghimi SM
    ACS Nano; 2010 Nov; 4(11):6629-38. PubMed ID: 21028845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled biotransesterified cyclodextrins as potential Artemisinin nanocarriers. II: In vitro behavior toward the immune system and in vivo biodistribution assessment of unloaded nanoparticles.
    Yaméogo JB; Gèze A; Choisnard L; Putaux JL; Mazet R; Passirani C; Keramidas M; Coll JL; Lautram N; Bejaud J; Semdé R; Wouessidjewe D
    Eur J Pharm Biopharm; 2014 Nov; 88(3):683-94. PubMed ID: 25204521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances on the complement system of teleost fish.
    Boshra H; Li J; Sunyer JO
    Fish Shellfish Immunol; 2006 Feb; 20(2):239-62. PubMed ID: 15950490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation on surfaces modified with ethylene glycol units.
    Arima Y; Toda M; Iwata H
    Biomaterials; 2008 Feb; 29(5):551-60. PubMed ID: 17981322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein interactions with surfaces: cellular responses, complement activation, and newer methods.
    Szott LM; Horbett TA
    Curr Opin Chem Biol; 2011 Oct; 15(5):677-82. PubMed ID: 21665522
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement and bacteria: chemistry and biology in host defense.
    Joiner KA; Brown EJ; Frank MM
    Annu Rev Immunol; 1984; 2():461-91. PubMed ID: 6399850
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement activation on degraded polyethylene glycol-covered surface.
    Toda M; Arima Y; Iwata H
    Acta Biomater; 2010 Jul; 6(7):2642-9. PubMed ID: 20123047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in assay of complement function and activation.
    Harboe M; Thorgersen EB; Mollnes TE
    Adv Drug Deliv Rev; 2011 Sep; 63(12):976-87. PubMed ID: 21664392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908.
    Moghimi SM; Pavey KD; Hunter AC
    FEBS Lett; 2003 Jul; 547(1-3):177-82. PubMed ID: 12860409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement resistance mechanisms of Klebsiella pneumoniae.
    Doorduijn DJ; Rooijakkers SH; van Schaik W; Bardoel BW
    Immunobiology; 2016 Oct; 221(10):1102-9. PubMed ID: 27364766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy.
    Dézsi L; Mészáros T; Őrfi E; Fülöp TG; Hennies M; Rosivall L; Hamar P; Szebeni J; Szénási G
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31505853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the complexation phenomenon and biological activity in vitro of polyplexes based on Tetronic T901 and DNA.
    Cambón A; Villar-Alvarez E; Alatorre-Meda M; Pardo A; Hiram B; Barbosa S; Taboada P; Mosquera V
    J Colloid Interface Sci; 2018 Jun; 519():58-70. PubMed ID: 29482097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal/permeability-increasing protein promotes complement activation for neutrophil-mediated phagocytosis on bacterial surface.
    Nishimura H; Gogami A; Miyagawa Y; Nanbo A; Murakami Y; Baba T; Nagasawa S
    Immunology; 2001 Aug; 103(4):519-25. PubMed ID: 11529944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.